|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,228.90 INR | -1.28% |
|
+4.14% | -8.67% |
| 10:36pm | Concord Biotech Limited, Q3 2026 Earnings Call, Feb 12, 2026 | |
| 11/02 | Concord Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CONCORDBIO Stock
- Consensus Concord Biotech Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition